Based on a unified board of 300 KR·US·JP stocks · updated July 18, 2026 at 10:27 AM KST
Johnson & Johnson is 14.0× Samsung Biologics
As of July 18, 2026 at 10:27 AM KST, Johnson & Johnson (JNJ) has a market cap of $609B — #15 worldwide — while Samsung Biologics (207940.KS) stands at $43B, ranking #138. The gap is $566B; Samsung Biologics is 7.1% the size of Johnson & Johnson.
Johnson & Johnson ranks #13 among US stocks (Healthcare), and Samsung Biologics ranks #8 among Korea stocks (Healthcare).
If Samsung Biologics reached Johnson & Johnson's market cap, its share price would need to go from $938.51 to $13158.56 (about +1302%).